Navigation Links
TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints
Date:3/12/2010

TAIPEI, Taiwan, March 12 /PRNewswire-Asia/ -- TaiGen Biotechnology Co., Ltd. announced today the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability. Nemonoxacin is a novel non-fluorinated quinolone that has a broad spectrum of activity against gram-positive and gram-negative bacteria and atypical pathogens. Importantly, nemonoxacin possesses activities against Methicillin-Resistant Staphylococcus aureus (MRSA) and vancomycin-resistant pathogens. This single arm, proof-of-concept study was conducted in US, South Africa, Thailand and Taiwan in mild to moderate DFI patients who were treated with nemonoxacin 750mg once daily for one or two weeks. Nemonoxacin showed higher clinical and microbiology success rates compared with previous DFI trials. Among the 40 enrolled patients, there were four MRSA-infected patients, including one patient with quinolone-resistant MRSA, who were clinically successful treated. Nemonoxacin also demonstrated excellent pharmacokinetic profile in tissue penetration and relatively low drug-drug interactions in this group of patients who received multiple medications concomitantly for other disease conditions.

"In addition to the top-line efficacy and safety data from our early phase 2 Community-Acquired Pneumonia (CAP) trial, we are very encouraged by the DFI data. With the clinically proven superior anti-MRSA activity and efficacy in DFI patients - a very difficult-to-treat patient population, we believe nemon
'/>"/>

SOURCE TaiGen Biotechnology Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... , March 1, 2015  USPlabs has notified ... following and states that media reports saying that ... On Saturday, February 28, 2015, the Center ... Public Notification on the contamination of a dietary ... (referred to below as "OEP") with a prescription ...
(Date:2/27/2015)... , Feb. 27, 2015 WuXi PharmaTech (Cayman) ... technology platform company serving the pharmaceutical, biotechnology, and medical ... and the United States , ... designation from the U.S. FDA for ibalizumab (TMB355). The ... it is intended, alone or in combination with one ...
(Date:2/27/2015)... WASHINGTON , Feb. 27, 2015  Following ... Means Committee that moved H.R. 284, the Medicare ... the American Association for Homecare (AAHomecare) released a ... quick action to pass the legislation. ... in the House Ways and Means Committee is ...
Breaking Medicine Technology:OEP Product Is Counterfeit 2WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2
... be needed to achieve desired anticoagulant effect in some ... October 8 , SILVER SPRING, Md., Oct. 1 ... health care professionals to a change in heparin manufacturing ... common blood-clotting drug. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , ...
... Accuray Incorporated (Nasdaq: ARAY ), a global leader ... results from a study of early stage prostate cancer ... erectile function was preserved in 81 percent of patients ... of erectile function preservation at two years for other ...
Cached Medicine Technology:FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency 2FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 4
(Date:2/28/2015)... MO (PRWEB) February 28, 2015 ... provider of outsourced sales, marketing and supply chain ... client, BIOTA Botanicals, is bringing its award winning ... worldwide, BIOTA Botanicals’ products are specifically created to ... care experts, BIOTA is committed to marrying science ...
(Date:2/28/2015)... February 28, 2015 India Network ... sponsored visitor health insurance programs for visitors coming to ... Indian elderly parents traveling to the United States are ... diabetes and blood pressure. These diseases are so common ... list them as medical conditions. There were 66.8 million ...
(Date:2/28/2015)... 28, 2015 Kaylie Corrigan, Outdoor Supervisor ... center , and current student obtaining her Masters degree ... a weekly forum in psychoeducation on substance use for ... AZ as part of her studies. , “Even though ... support and counseling at the high school and junior ...
(Date:2/28/2015)... 2015 On Thursday, February 26th, Forbes published ... For Scammers To Steal Your Data , which stresses the ... on a DIY phishing kit, or any kind of malware ... another important point about how everyone’s cyber security is intertwined ... “like compromising legitimate content management systems or blogs in order ...
(Date:2/28/2015)... The noted Toronto plastic surgeon Dr. ... recently featured in the January/February 2015 issue of Elevate ... Ellis was featured in an article entitled “Get the ... that Kim Cattrall has possibly undergone to maintain her ... smooth without horizontal lines or frown line creases, which ...
Breaking Medicine News(10 mins):Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Dr. David Ellis Featured In Elevate Magazine 2
... and Nurse Training Needed, Experts Say, PHILADELPHIA, ... Supply, an independent group of healthcare leaders based ... White House to convene a,special conference to address ... to healthcare services cannot be maintained, let alone,expanded, ...
... Pa., March 26 WPCS International,Incorporated (Nasdaq: ... engineering services,for specialty communication systems and wireless ... has been awarded approximately,$12 million in new ... be completed for The University of,Connecticut, The ...
... Uses of Gourmetceuticals, ... and PPL-240(TM), BIG HORN, Wyo., March 26 ... and scientifically validated,ingredients for use in foods and ... GLPH-1, an immune booster, and,PPL-240, an antioxidant, will ...
... Mich., March 26 The next phase of,Michigan,s ... be lead by,CJPS Enterprises, LLC (http://www.CJPS-Enterprises.com ). ... Corporation to create a,network of researchers, entrepreneurs and ... project. The project was created through the $2,billion ...
... ... http://www.cryocath.com , ... leader in cryotherapy products to treat cardiac,arrhythmias, today announced the ... product for the treatment of,paroxysmal atrial fibrillation (PAF), is a ...
... Results from the third annual Alzheimers Foundation of ... suggest that Alzheimers disease care is a family affair. ... children under 21 who also care for an aging ... say their children are assisting with caregiving responsibilities that ...
Cached Medicine News:Health News:Council Calls on White House to Convene Conference on Physician and Nurse Supply 2Health News:WPCS Announces $12 Million in New Projects 2Health News:Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008 2Health News:CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline 2Health News:CryoCath Introduces Arctic Front in Australia 2Health News:CryoCath Introduces Arctic Front in Australia 3Health News:New Alzheimer's disease survey reveals children of sandwich caregivers assist with loved ones' care 2Health News:New Alzheimer's disease survey reveals children of sandwich caregivers assist with loved ones' care 3
... The Infinity Uric Acid single liquid ... the convenience of single liquid stability ... operator error and provide quick result ... the Infinity Uric Acid reagent provides ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
... Creatinine single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... reagent provides a long shelf life ...
... practice by seeing more patients per day. Utilizing ... turn a 14-18 patients per day practice into ... automated test sequences, youll perform accurate refractions in ... learn; making it easy to delegate tasks to ...
Medicine Products: